Dog · Canis lupus familiaris · typical adult weight 2.00–80.00 kg
Ilunocitinib is dosed at 0.6–1.8 mg/kg PO q24h in dogs, per FDA conditional approval data; FDA openFDA Adverse Event Database. Ilunocitinib is used in dogs for Atopic dermatitis, allergic pruritus. Routes documented in dogs: PO. A typical adult dog weighs 2.00–80.00 kg. ExoticRx lists 1 cited dose rule for Ilunocitinib in dogs, drawn from published veterinary references. Verify against current literature before clinical use.
US trade names: Greylan
| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| PO | 0.6–1.8 mg/kg | q24h | Initial 14-day course; then as-needed or maintenance dosing | Atopic dermatitis, allergic pruritus | Moderate | FDA conditional approval data; FDA openFDA Adverse Event Database |
Need the exact dose for your patient?
These ranges are per kg. Enter your dog's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
Selective Janus kinase 1 (JAK1) inhibitor that blocks cytokine signaling pathways involved in pruritus and inflammation, reducing itch and allergic skin inflammation in dogs.
New veterinary JAK inhibitor with limited post-market data. Monitor CBC and liver values. May increase susceptibility to infections. Similar class warnings to oclacitinib.
Species-specific contraindications and adverse-reaction reports for dogs may differ from canine / feline reference data — consult the primary citations listed with each rule.
Ilunocitinib dose range in dogs, with cited source references: PO 0.6–1.8 mg/kg q24h. Reference ranges from cited sources — verify against current literature before clinical use.
Documented routes for Ilunocitinib in dogs: PO.
Cited course lengths for Ilunocitinib in dogs include: Initial 14-day course; then as-needed or maintenance dosing. Duration depends on the indication — match it to the specific dose rule in the table above.
Ilunocitinib is indicated in dogs for: Atopic dermatitis, allergic pruritus.
These are general warnings for Ilunocitinib across species; consult the dog dosing table above for species-specific guidance. New veterinary JAK inhibitor with limited post-market data. Monitor CBC and liver values. May increase susceptibility to infections. Similar class warnings to oclacitinib.
Why a species-specific page? Ilunocitinib pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in dogs — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.